170 related articles for article (PubMed ID: 32192199)
1. Benzothiazolyl Ureas are Low Micromolar and Uncompetitive Inhibitors of 17β-HSD10 with Implications to Alzheimer's Disease Treatment.
Schmidt M; Benek O; Vinklarova L; Hrabinova M; Zemanova L; Chribek M; Kralova V; Hroch L; Dolezal R; Lycka A; Prchal L; Jun D; Aitken L; Gunn-Moore F; Kuca K; Musilek K
Int J Mol Sci; 2020 Mar; 21(6):. PubMed ID: 32192199
[TBL] [Abstract][Full Text] [Related]
2. Design, synthesis and in vitro evaluation of benzothiazole-based ureas as potential ABAD/17β-HSD10 modulators for Alzheimer's disease treatment.
Hroch L; Benek O; Guest P; Aitken L; Soukup O; Janockova J; Musil K; Dohnal V; Dolezal R; Kuca K; Smith TK; Gunn-Moore F; Musilek K
Bioorg Med Chem Lett; 2016 Aug; 26(15):3675-8. PubMed ID: 27287370
[TBL] [Abstract][Full Text] [Related]
3. Synthesis and evaluation of frentizole-based indolyl thiourea analogues as MAO/ABAD inhibitors for Alzheimer's disease treatment.
Hroch L; Guest P; Benek O; Soukup O; Janockova J; Dolezal R; Kuca K; Aitken L; Smith TK; Gunn-Moore F; Zala D; Ramsay RR; Musilek K
Bioorg Med Chem; 2017 Feb; 25(3):1143-1152. PubMed ID: 28082069
[TBL] [Abstract][Full Text] [Related]
4. Novel Benzothiazole-based Ureas as 17β-HSD10 Inhibitors, A Potential Alzheimer's Disease Treatment.
Aitken L; Benek O; McKelvie BE; Hughes RE; Hroch L; Schmidt M; Major LL; Vinklarova L; Kuca K; Smith TK; Musilek K; Gunn-Moore FJ
Molecules; 2019 Jul; 24(15):. PubMed ID: 31362457
[No Abstract] [Full Text] [Related]
5. Crystal structure of human ABAD/HSD10 with a bound inhibitor: implications for design of Alzheimer's disease therapeutics.
Kissinger CR; Rejto PA; Pelletier LA; Thomson JA; Showalter RE; Abreo MA; Agree CS; Margosiak S; Meng JJ; Aust RM; Vanderpool D; Li B; Tempczyk-Russell A; Villafranca JE
J Mol Biol; 2004 Sep; 342(3):943-52. PubMed ID: 15342248
[TBL] [Abstract][Full Text] [Related]
6. Infantile Neurodegeneration Results from Mutants of 17β-Hydroxysteroid Dehydrogenase Type 10 Rather Than Aβ-Binding Alcohol Dehydrogenase.
He XY; Dobkin C; Brown WT; Yang SY
Int J Mol Sci; 2023 May; 24(10):. PubMed ID: 37239833
[TBL] [Abstract][Full Text] [Related]
7. 6-benzothiazolyl ureas, thioureas and guanidines are potent inhibitors of ABAD/17β-HSD10 and potential drugs for Alzheimer's disease treatment: Design, synthesis and in vitro evaluation.
Benek O; Hroch L; Aitken L; Dolezal R; Guest P; Benkova M; Soukup O; Musil K; Kuca K; Smith TK; Gunn-Moore F; Musilek K
Med Chem; 2017 Jan; ():. PubMed ID: 28067167
[TBL] [Abstract][Full Text] [Related]
8. Nanomolar Benzothiazole-Based Inhibitors of 17β-HSD10 with Cellular Bioactivity.
Hanzlova M; Miskerikova MS; Rotterova A; Chalupova K; Jurkova K; Hamsikova M; Andrys R; Haleckova A; Svobodova J; Schmidt M; Benek O; Musilek K
ACS Med Chem Lett; 2023 Dec; 14(12):1724-1732. PubMed ID: 38116418
[TBL] [Abstract][Full Text] [Related]
9. Physiologically relevant fluorescent assay for identification of 17β-hydroxysteroid dehydrogenase type 10 inhibitors.
Schmidt M; Vaskova M; Rotterova A; Fiandova P; Miskerikova M; Zemanova L; Benek O; Musilek K
J Neurochem; 2023 Oct; 167(2):154-167. PubMed ID: 37458164
[TBL] [Abstract][Full Text] [Related]
10. 3-Hydroxyacyl-CoA and Alcohol Dehydrogenase Activities of Mitochondrial Type 10 17β-Hydroxysteroid Dehydrogenase in Neurodegeneration Study.
He XY; Dobkin C; Brown WT; Yang SY
J Alzheimers Dis; 2022; 88(4):1487-1497. PubMed ID: 35786658
[TBL] [Abstract][Full Text] [Related]
11. In Vitro Assay Development and HTS of Small-Molecule Human ABAD/17β-HSD10 Inhibitors as Therapeutics in Alzheimer's Disease.
Aitken L; Baillie G; Pannifer A; Morrison A; Jones PS; Smith TK; McElroy SP; Gunn-Moore FJ
SLAS Discov; 2017 Jul; 22(6):676-685. PubMed ID: 28314118
[TBL] [Abstract][Full Text] [Related]
12. Development of submicromolar 17β-HSD10 inhibitors and their in vitro and in vivo evaluation.
Benek O; Vaskova M; Miskerikova M; Schmidt M; Andrys R; Rotterova A; Skarka A; Hatlapatkova J; Karasova JZ; Medvecky M; Hroch L; Vinklarova L; Fisar Z; Hroudova J; Handl J; Capek J; Rousar T; Kobrlova T; Dolezal R; Soukup O; Aitken L; Gunn-Moore F; Musilek K
Eur J Med Chem; 2023 Oct; 258():115593. PubMed ID: 37390508
[TBL] [Abstract][Full Text] [Related]
13. Roles of Mitochondrial 17β-Hydroxysteroid Dehydrogenase Type 10 in Alzheimer's Disease.
He XY; Isaacs C; Yang SY
J Alzheimers Dis; 2018; 62(2):665-673. PubMed ID: 29480196
[TBL] [Abstract][Full Text] [Related]
14. Friend or enemy? Review of 17β-HSD10 and its role in human health or disease.
Vinklarova L; Schmidt M; Benek O; Kuca K; Gunn-Moore F; Musilek K
J Neurochem; 2020 Nov; 155(3):231-249. PubMed ID: 32306391
[TBL] [Abstract][Full Text] [Related]
15. Identification of a 17β-hydroxysteroid dehydrogenase type 10 steroidal inhibitor: a tool to investigate the role of type 10 in Alzheimer's disease and prostate cancer.
Ayan D; Maltais R; Poirier D
ChemMedChem; 2012 Jul; 7(7):1181-4. PubMed ID: 22674910
[No Abstract] [Full Text] [Related]
16. Hydroxysteroid (17β) dehydrogenase X in human health and disease.
Yang SY; He XY; Miller D
Mol Cell Endocrinol; 2011 Aug; 343(1-2):1-6. PubMed ID: 21708223
[TBL] [Abstract][Full Text] [Related]
17. Identification of small-molecule inhibitors of the Abeta-ABAD interaction.
Xie Y; Deng S; Chen Z; Yan S; Landry DW
Bioorg Med Chem Lett; 2006 Sep; 16(17):4657-60. PubMed ID: 16781151
[TBL] [Abstract][Full Text] [Related]
18. Identification of steroidal derivatives inhibiting the transformations of allopregnanolone and estradiol by 17β-hydroxysteroid dehydrogenase type 10.
Boutin S; Roy J; Maltais R; Alata W; Calon F; Poirier D
Bioorg Med Chem Lett; 2018 Dec; 28(22):3554-3559. PubMed ID: 30297283
[TBL] [Abstract][Full Text] [Related]
19. Multiple functions of type 10 17beta-hydroxysteroid dehydrogenase.
Yang SY; He XY; Schulz H
Trends Endocrinol Metab; 2005; 16(4):167-75. PubMed ID: 15860413
[TBL] [Abstract][Full Text] [Related]
20. Recognition of structurally diverse substrates by type II 3-hydroxyacyl-CoA dehydrogenase (HADH II)/amyloid-beta binding alcohol dehydrogenase (ABAD).
Powell AJ; Read JA; Banfield MJ; Gunn-Moore F; Yan SD; Lustbader J; Stern AR; Stern DM; Brady RL
J Mol Biol; 2000 Oct; 303(2):311-27. PubMed ID: 11023795
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]